CLEO Selects U.S. Clinical Trial Sites
MELBOURNE, AUSTRALIA, 31 July 2024: Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce progress for its U.S. clinical trials in support of…
Input your search keywords and press Enter.